Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-045292
Filing Date
2021-11-18
Accepted
2021-11-18 18:00:38
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8663
  Complete submission text file 0000899243-21-045292.txt   10110
Mailing Address C/O INTERACTIVE CORP 152 W. 57TH ST. NEW YORK NY 10019
Business Address
BLATT GREGORY R (Reporting) CIK: 0001206793 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41058 | Film No.: 211425803

Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations